The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032, expanding at a CAGR of 6.2% over the 2022-2032 time frame.
Feature | Cardiogenic Shock
Cardiogenic Shock Market Outlook

The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032 ...

Home May 12, 2022
Home
Integrated patch offers ECG, heart rate, respiratory rate, and blood pressure monitoring for commercial research and development
News | Remote Monitoring
Vivalink Announces World’s First Multi-Vital Blood Pressure Patch for Remote Patient Monitoring

May 12, 2022 — Vivalink, a leading provider of digital healthcare solutions, announced availability of the world’s first ...

Home May 12, 2022
Home
Peter Mackrell, MD
News | Cardiovascular Business
Board Certified Vascular Surgeon Joins NDA Partners as Expert Consultant

May 12, 2022 — NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified ...

Home May 12, 2022
Home
NIH-funded study explains factors linked to increased risk for heart attack or stroke among women who have pregnancy problems related to high blood pressure
News | Womens Cardiovascular Health
Hypertensive Pregnancy Disorders Linked to Future Cardiac Events

May 11, 2022 — Women who experienced complications related to developing high blood pressure, or hypertension, during ...

Home May 11, 2022
Home
A microscopy picture of muscle cells in a normal heart (left) and muscle cells in a heart of a patient with hypertrophic cardiomyopathy (right). The black areas are single muscle cells. The muscle cells of the hypertrophic cardiomyopathy patient are bigger, and there is more space in between the cells (green), which is filled with scar tissues in the case of patients with hypertrophic cardiomyopathy. The blue indicates where the DNA of the cells can be found. Image courtesy of Anne de Leeuw, copyright Hubre
News | Cardiovascular Clinical Studies
Single Cell RNA Sequencing Uncovers New Mechanisms of Heart Disease

May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a ...

Home May 11, 2022
Home
Gay Nord
News | Cardiovascular Business
Vital Heart & Vein Names Gay Nord, MHA as New CEO

May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its new ...

Home May 11, 2022
Home
Back on track after its in-person hiatus, ACC22 stressed industry resilience, and featured practice-changing science and innovations
Feature | ACC | By Melinda Taschetta-Millane
ACC22: Transforming Cardiovascular Care

In April, the cardiology community converged face-to-face in Orlando for The American College of Cardiology’s (ACC22) ...

Home May 11, 2022
Home
The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end. This feature has demonstrated in simulated use studies that the Q Catheter may be uniquely suited to allow physicians in the future to treat ischemic stroke patients remotely via a robot from a different room, a different city, or even a different country. 
News | Catheters
WLNC Highlights Q Catheter Compatibility in Simulated Robotic Thrombectomy

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, has been selected as the winner of the “Best New Ultrasound Solution” award in the sixth annual MedTech Breakthrough Awards program.
News | Cardiovascular Ultrasound
Butterfly Network Recognized As “Best New Ultrasound Solution” in 2022 MedTech Breakthrough Awards Program

May 10, 2022 — MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies ...

Home May 10, 2022
Home
After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) looks forward to welcoming more than 2,000 attendees to an exciting, fully live meeting in Atlanta, May 19-22.
News | SCAI
SCAI22 Scientific Sessions

May 10, 2022 — After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) ...

Home May 10, 2022
Home
Iocyte AMI-3 Trial to assess effectiveness and safety of FDY-5301 in improving outcomes for anterior STEMI patients undergoing primary PCI
News | STEMI
Faraday Pharmaceuticals Announces First Patient Enrolled in Phase 3 Trial for Myocardial Infarction

May 10, 2022 — Faraday Pharmaceuticals, Inc., today announced the enrollment of the first patient in its Iocyte AMI-3 ...

Home May 10, 2022
Home
Heart failure presents differently in women and men – discover the latest evidence and its impact on management at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).
News | ESC
Improving Outcomes for all Patients with Heart Failure

May 9, 2022 — Heart failure presents differently in women and men – discover the latest evidence and its impact on ...

Home May 09, 2022
Home
Primary tabs View(active tab) Edit Delete Revisions Entityqueue Devel Open configuration options Open configuration options Videos | Venous Therapies | June 27, 2017 VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots Open Related Chest Pain Imaging Content: configuration options Venous Thrombolytic System Demonstration Play Mute Remaining Time -3:23 Picture-in-Picture Fullscreen This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat dee
Feature | Cardiovascular Business
Top 10 Cardiology Videos on DAIC for April

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...

Home May 09, 2022
Home
Heart failure patients implanted with Barostim can now receive conditional MRI scans
News | Magnetic Resonance Imaging (MRI)
CVRx Receives MR-conditional Labeling Approval for its Barostim Heart Failure System

May 9, 2022 — CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of ...

Home May 09, 2022
Home
COVID-19 had a profound impact on the cardiovascular imaging system in 2020.
Feature | Cardiovascular Ultrasound
Cardiovascular Ultrasound Market Forecast

The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period ...

Home May 05, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now